HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

DICE Therapeutics, Inc.

1
Articles
Deal Party
Top Role
Apr 9, 2026
First Mention
Apr 9, 2026
Last Mention
1.33
Relevance Score

Coverage Timeline

April 2026
Eli Lilly's $2.4 Billion DICE Therapeutics Bet: Pipeline Risk, Platform Ambition, and Autoimmune Expansion Deals Deal Party
Apr 9, 2026
Lilly revealed its $2.4 billion acquisition of DICE Therapeutics in June 2023.
Related Companies
Kyowa Kirin Co., Ltd.
1 shared
Arena Pharmaceuticals, Inc.
1 shared
Amgen Inc.
1 shared
Novartis AG
1 shared
Eli Lilly and Company
1 shared
Pfizer Inc.
1 shared